{"id":"https://openalex.org/W1876192519","doi":null,"title":"Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.","display_name":"Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.","publication_year":1997,"publication_date":"1997-06-15","ids":{"openalex":"https://openalex.org/W1876192519","mag":"1876192519","pmid":"https://pubmed.ncbi.nlm.nih.gov/9192825"},"language":"en","primary_location":{"id":"pmid:9192825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9192825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071802884","display_name":"Gary Anthony Piazza","orcid":"https://orcid.org/0000-0003-4418-887X","observed_orcids":["https://orcid.org/0000-0003-4418-887X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Piazza","raw_affiliation_strings":["Cell Pathways, Inc., Denver, Colorado 80012-4526, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Pathways, Inc., Denver, Colorado 80012-4526, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070619892","display_name":"A K Rahm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A K Rahm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111499038","display_name":"T S Finn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T S Finn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067209609","display_name":"B Fryer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B H Fryer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102801964","display_name":"Han Li","orcid":"https://orcid.org/0000-0002-3599-7950","observed_orcids":["https://orcid.org/0000-0002-3599-7950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080008039","display_name":"A L Stoumen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A L Stoumen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012051429","display_name":"Rifat Pamukcu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Pamukcu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078332522","display_name":"Dennis J. Ahnen","orcid":"https://orcid.org/0000-0003-1783-1129","observed_orcids":["https://orcid.org/0000-0003-1783-1129"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J Ahnen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":16.3296,"has_fulltext":false,"cited_by_count":350,"citation_normalized_percentile":{"value":0.99483109,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"57","issue":"12","first_page":"2452","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibition","display_name":"cyclooxygenase inhibition","score":0.7409999966621399},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8790000081062317},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.972000002861023},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.7720000147819519},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8759999871253967},{"id":"https://openalex.org/keywords/sulfide","display_name":"sulfide","score":0.43700000643730164},{"id":"https://openalex.org/keywords/sulfones","display_name":"sulfones","score":0.9879999756813049},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9399999976158142},{"id":"https://openalex.org/keywords/colon-adenocarcinoma-cells","display_name":"colon adenocarcinoma cells","score":0.8690000176429749},{"id":"https://openalex.org/keywords/familial-adenomatous-polyposis","display_name":"familial adenomatous polyposis","score":0.8769999742507935},{"id":"https://openalex.org/keywords/saos-2-cells","display_name":"Saos-2 cells","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C2776241388","wikidata":"https://www.wikidata.org/wiki/Q963093","display_name":"Sulindac","level":3,"score":0.9683111906051636},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.7050015926361084},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6932476758956909},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.573371410369873},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5718254446983337},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5309550166130066},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5253283977508545},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.4746449589729309},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46293821930885315},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4609200954437256},{"id":"https://openalex.org/C2777956040","wikidata":"https://www.wikidata.org/wiki/Q416554","display_name":"Prostaglandin E2","level":2,"score":0.41620171070098877},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32927167415618896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31983816623687744},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2743276357650757},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26209399104118347},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1338057816028595},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006131","descriptor_name":"Growth Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013467","descriptor_name":"Sulindac","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013467","descriptor_name":"Sulindac","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015064","descriptor_name":"16,16-Dimethylprostaglandin E2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9192825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9192825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1876192519","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9192825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W175540666","https://openalex.org/W1539601638","https://openalex.org/W1564536213","https://openalex.org/W1606427125","https://openalex.org/W1925690329","https://openalex.org/W1928411162","https://openalex.org/W1973577382","https://openalex.org/W1979319210","https://openalex.org/W1995978700","https://openalex.org/W2003206908","https://openalex.org/W2008574207","https://openalex.org/W2018231352","https://openalex.org/W2026307857","https://openalex.org/W2029431152","https://openalex.org/W2029758835","https://openalex.org/W2032122995","https://openalex.org/W2043707891","https://openalex.org/W2044189814","https://openalex.org/W2059689162","https://openalex.org/W2064610337","https://openalex.org/W2065851152","https://openalex.org/W2081961402","https://openalex.org/W2084647545","https://openalex.org/W2087224686","https://openalex.org/W2109689528","https://openalex.org/W2169682004","https://openalex.org/W2169790726","https://openalex.org/W2336215030","https://openalex.org/W2412366243"],"related_works":["https://openalex.org/W1539601638","https://openalex.org/W1976516830","https://openalex.org/W2589296592","https://openalex.org/W7100740236","https://openalex.org/W2044280607","https://openalex.org/W2091165828","https://openalex.org/W2371516798","https://openalex.org/W2161376238","https://openalex.org/W2109401985","https://openalex.org/W2013165612"],"abstract_inverted_index":{"Sulindac":[0,167],"causes":[1],"regression":[2],"of":[3,7,27,40,43,54,74,96,106,164,210],"and":[4,20,56,60,67,70,85,99,117,199,261],"prevents":[5],"recurrence":[6],"colonic":[8],"adenomas":[9],"in":[10,45,174,181,191,204],"patients":[11],"with":[12,77,196,212],"familial":[13],"adenomatous":[14],"polyposis.":[15],"Although":[16],"cell":[17,57,171],"cycle":[18,58,172],"arrest":[19,59,173],"apoptosis":[21,55,91,121,241],"have":[22],"been":[23],"proposed,":[24],"the":[25,37,52,61,72,78,93,97,130,139,153,161,165,268],"mechanism":[26],"action":[28],"is":[29],"poorly":[30],"understood.":[31],"In":[32,184],"this":[33],"study,":[34],"we":[35],"characterized":[36],"growth-inhibitory":[38,94],"effects":[39,73,95,163],"active":[41],"metabolites":[42,76,168,198,220,233],"sulindac":[44,75,197,219,232,248],"cultured":[46],"colon":[47],"adenocarcinoma":[48],"cells":[49,176,211],"by":[50,247],"determining":[51],"contribution":[53],"requirement":[62],"for":[63,114,141,149],"cyclooxygenase":[64],"(COX)":[65],"inhibition":[66,116,246,257],"p53":[68,215,259],"involvement":[69],"compared":[71],"chemotherapeutic":[79],"drug,":[80],"5-fluorouracil":[81],"(5-FU).":[82],"Time":[83],"course":[84],"dose-response":[86],"experiments":[87],"demonstrated":[88],"that":[89,240],"increased":[90,214],"paralleled":[92],"sulfide":[98,140],"sulfone.":[100],"A":[101],"relationship":[102],"among":[103],"a":[104],"series":[105],"nonsteroidal":[107],"anti-inflammatory":[108],"drugs":[109],"was":[110,132,188],"observed":[111],"between":[112],"potency":[113,124],"growth":[115,245],"ability":[118],"to":[119,125,159,231,244,263,271],"induce":[120,223],"but":[122,144,177,234],"not":[123,202,222,235,254],"inhibit":[126],"COX.":[127],"For":[128],"example,":[129],"sulfone":[131],"at":[133],"least":[134],"5000-fold":[135],"less":[136,147,189],"potent":[137,148],"than":[138],"inhibiting":[142],"COX":[143,256],"only":[145],"6.5-fold":[146],"inducing":[150],"apoptosis.":[151],"Moreover,":[152],"prostaglandin":[154],"analogue,":[155],"dimethyl-prostaglandin":[156],"E2,":[157],"failed":[158],"reverse":[160],"apoptosis-inducing":[162],"sulfide.":[166],"caused":[169],"G1":[170],"proliferating":[175],"were":[178],"comparably":[179],"effective":[180,190],"nonproliferating":[182,192],"cells.":[183,193],"contrast,":[185],"5-FU":[186,200,213],"treatment":[187,195],"Combined":[194],"did":[201,221],"result":[203],"an":[205],"additive":[206],"apoptotic":[207,269],"response.":[208],"Treatment":[209],"protein":[216],"levels,":[217],"whereas":[218],"expression.":[224],"Saos-2":[225],"cells,":[226],"which":[227],"lack":[228],"p53,":[229],"responded":[230],"5-FU.":[236,272],"These":[237],"results":[238],"show":[239],"primarily":[242],"contributes":[243],"metabolites.":[249],"The":[250],"biochemical":[251],"pathway":[252],"does":[253],"require":[255],"or":[258],"induction":[260],"appears":[262],"be":[264],"fundamentally":[265],"different":[266],"from":[267],"response":[270]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}